Examples of using Hepatic function should in English and their translations into Greek
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Official/political
-
Computer
Renal and hepatic function should be monitored.
Dose modification due to non haematological toxicity Periodic physical examination and checks of renal and hepatic function should be made to detect non haematological toxicity.
Renal and hepatic function should be closely monitored.
Dose modification due to non haematological toxicity Periodic physical examination and checks of renal and hepatic function should be made to detect non- 19 haematological toxicity.
Renal and hepatic function should be closely monitored.
If the treatment is continued, hepatic function should be monitored closely.
Hepatic function should be monitored in both children and adults.
It should also be noted that patients with impaired renal and hepatic function should apply the medication in question with extreme caution.
Hepatic function should be monitored regularly whilst on treatment.
Patients with impaired hepatic function should be advised by a doctor before taking Losec(see section 5.2).
Hepatic function should be monitored at repeated intervals with both clinical and laboratory follow-up for at least 6 months after discontinuation of hepatitis B therapy.
Renal and hepatic function should be assessed with the following chemistry studies.
Hepatic function should be monitored at repeated intervals with both clinical and laboratory follow-up for at least 6 months after discontinuation of hepatitis B therapy.
Monitoring of hepatic function should be carried out in both children and adults.
Hepatic function should be carefully monitored in circumstances where imatinib is combined with chemotherapy regimens also known to be associated with hepatic dysfunction(see sections 4.5 and 4.8).
Liver enzymes and hepatic function should be regularly controlled in patients with longterm ropeginterferon alfa-2b therapy.
Hepatic function should be closely monitored during treatment with meropenem/vaborbactam due to the risk of hepatic toxicity(hepatic dysfunction with cholestasis and cytolysis)(see section 4.8).
Renal and hepatic function should be monitored in these patient populations during deferiprone therapy.
Hepatic function should be closely monitored during treatment with imipenem/cilastatin due to the risk of hepatic toxicity(such as increase in transaminases,hepatic failure and fulminant hepatitis).
The haematological status of the patient,as well as renal and hepatic functions should be determined prior to, and repeatedly during treatment.